AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Hudson Thomas J | Officer | Aug 08 '24 | Proposed Sale | 189.08 | 49,170 | 9,297,210 | | Aug 08 05:40 PM | | GONZALEZ RICHARD A | EXECUTIVE CHAIRMAN OF BOARD | Aug 05 '24 | Sale | 186.52 | 66,500 | 12,403,580 | 446,599 | Aug 07 05:00 PM | | Hudson Thomas J | Officer | Aug 07 '24 | Proposed Sale | 187.62 | 101,886 | 19,115,380 | | Aug 07 04:22 PM | | GONZALEZ RICHARD A | Officer | Aug 05 '24 | Proposed Sale | 187.36 | 66,500 | 12,459,360 | | Aug 05 10:54 AM | | GONZALEZ RICHARD A | EXECUTIVE CHAIRMAN OF BOARD | Jul 17 '24 | Option Exercise | 77.49 | 282,845 | 21,919,048 | 795,944 | Jul 19 04:40 PM | | GONZALEZ RICHARD A | EXECUTIVE CHAIRMAN OF BOARD | Jul 17 '24 | Sale | 175.00 | 282,845 | 49,497,875 | 513,099 | Jul 19 04:40 PM | | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Mar 20 '24 | Sale | 176.30 | 21,082 | 3,716,757 | 55,903 | Mar 22 05:00 PM | | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Mar 18 '24 | Option Exercise | 61.36 | 26,110 | 1,602,110 | 119,890 | Mar 20 05:00 PM | | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Mar 18 '24 | Sale | 178.79 | 58,949 | 10,539,508 | 60,941 | Mar 20 05:00 PM | | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | Mar 01 '24 | Option Exercise | 61.36 | 45,700 | 2,804,152 | 89,517 | Mar 05 05:30 PM | | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | Mar 01 '24 | Sale | 177.27 | 75,680 | 13,415,503 | 13,837 | Mar 05 05:30 PM | | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Feb 23 '24 | Option Exercise | 61.36 | 14,140 | 867,630 | 41,205 | Mar 01 05:50 PM | | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Feb 23 '24 | Sale | 177.44 | 14,140 | 2,509,002 | 27,065 | Mar 01 05:50 PM | | Buckbee Kevin K | SVP, CONTROLLER | Feb 29 '24 | Sale | 176.65 | 5,144 | 908,688 | 6,983 | Mar 01 05:50 PM | | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | Feb 29 '24 | Option Exercise | 58.30 | 21,560 | 1,257,012 | 167,524 | Mar 01 05:50 PM | | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | Feb 29 '24 | Sale | 176.45 | 68,879 | 12,153,957 | 98,645 | Mar 01 05:50 PM | | Siatis Perry C | EVP, GC AND SECRETARY | Feb 29 '24 | Sale | 177.39 | 9,891 | 1,754,555 | 10,397 | Mar 01 05:50 PM | | GONZALEZ RICHARD A | CHAIRMAN OF THE BOARD AND CEO | Feb 28 '24 | Sale | 177.27 | 138,616 | 24,572,458 | 519,099 | Mar 01 05:50 PM | | Siatis Perry C | EVP, GC AND SECRETARY | Feb 23 '24 | Option Exercise | 137.36 | 13,753 | 1,889,115 | 41,926 | Feb 27 05:10 PM | | Siatis Perry C | EVP, GC AND SECRETARY | Feb 23 '24 | Sale | 177.51 | 13,753 | 2,441,295 | 28,173 | Feb 27 05:10 PM | | SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | Feb 21 '24 | Option Exercise | 58.88 | 52,870 | 3,112,986 | 296,814 | Feb 23 05:00 PM | | SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | Feb 21 '24 | Sale | 173.71 | 52,870 | 9,184,048 | 243,944 | Feb 23 05:00 PM | | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Dec 26 '23 | Sale | 154.72 | 2,912 | 450,545 | 55,903 | Dec 28 05:00 PM |
|
